124 related articles for article (PubMed ID: 20487262)
1. Administration route-dependent induction of antitumor immunity by interferon-alpha gene transfer.
Narumi K; Kondoh A; Udagawa T; Hara H; Goto N; Ikarashi Y; Ohnami S; Okada T; Yamagishi M; Yoshida T; Aoki K
Cancer Sci; 2010 Jul; 101(7):1686-94. PubMed ID: 20487262
[TBL] [Abstract][Full Text] [Related]
2. Intratumoral interferon-alpha gene transfer enhances tumor immunity after allogeneic hematopoietic stem cell transplantation.
Hara H; Kobayashi A; Narumi K; Kondoh A; Yoshida K; Nishimoto T; Ohashi M; Higashihara E; Ohnami S; Yoshida T; Aoki K
Cancer Immunol Immunother; 2009 Jul; 58(7):1007-21. PubMed ID: 18998126
[TBL] [Abstract][Full Text] [Related]
3. In vivo delivery of interferon-α gene enhances tumor immunity and suppresses immunotolerance in reconstituted lymphopenic hosts.
Narumi K; Udagawa T; Kondoh A; Kobayashi A; Hara H; Ikarashi Y; Ohnami S; Takeshita F; Ochiya T; Okada T; Yamagishi M; Yoshida T; Aoki K
Gene Ther; 2012 Jan; 19(1):34-48. PubMed ID: 21614029
[TBL] [Abstract][Full Text] [Related]
4. Local interferon-alpha gene therapy elicits systemic immunity in a syngeneic pancreatic cancer model in hamster.
Hara H; Kobayashi A; Yoshida K; Ohashi M; Ohnami S; Uchida E; Higashihara E; Yoshida T; Aoki K
Cancer Sci; 2007 Mar; 98(3):455-63. PubMed ID: 17233811
[TBL] [Abstract][Full Text] [Related]
5. Type I IFN gene delivery suppresses regulatory T cells within tumors.
Hashimoto H; Ueda R; Narumi K; Heike Y; Yoshida T; Aoki K
Cancer Gene Ther; 2014 Dec; 21(12):532-41. PubMed ID: 25430879
[TBL] [Abstract][Full Text] [Related]
6. Suppression of Tregs by anti-glucocorticoid induced TNF receptor antibody enhances the antitumor immunity of interferon-α gene therapy for pancreatic cancer.
Aida K; Miyakawa R; Suzuki K; Narumi K; Udagawa T; Yamamoto Y; Chikaraishi T; Yoshida T; Aoki K
Cancer Sci; 2014 Feb; 105(2):159-67. PubMed ID: 24289533
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus-mediated interferon alpha gene transfer induces regional direct cytotoxicity and possible systemic immunity against pancreatic cancer.
Ohashi M; Yoshida K; Kushida M; Miura Y; Ohnami S; Ikarashi Y; Kitade Y; Yoshida T; Aoki K
Br J Cancer; 2005 Aug; 93(4):441-9. PubMed ID: 16106250
[TBL] [Abstract][Full Text] [Related]
8. Adenovirus and retrovirus mediated interferon alpha gene transfer into CD34+ cells maintains regeneration capacity and enhances adhesion molecules in K562 cells.
Seiter K; Kancherla R; Yang L; Quan S; Farley TJ; Abraham NG; Ahmed T
J Investig Med; 1999 Sep; 47(8):414-24. PubMed ID: 10510594
[TBL] [Abstract][Full Text] [Related]
9. Preimmunization of donor lymphocytes enhances antitumor immunity of autologous hematopoietic stem cell transplantation.
Suzuki K; Aida K; Miyakawa R; Narumi K; Udagawa T; Yoshida T; Ohshima Y; Aoki K
Cancer Med; 2013 Oct; 2(5):636-45. PubMed ID: 24403229
[TBL] [Abstract][Full Text] [Related]
10. Combination of interleukin 12 and interferon alpha gene therapy induces a synergistic antitumor response against colon and renal cell carcinoma.
Mendiratta SK; Quezada A; Matar M; Thull NM; Bishop JS; Nordstrom JL; Pericle F
Hum Gene Ther; 2000 Sep; 11(13):1851-62. PubMed ID: 10986558
[TBL] [Abstract][Full Text] [Related]
11. Interferon alpha2b gene delivery using adenoviral vector causes inhibition of tumor growth in xenograft models from a variety of cancers.
Iqbal Ahmed CM; Johnson DE; Demers GW; Engler H; Howe JA; Wills KN; Wen SF; Shinoda J; Beltran J; Nodelman M; Machemer T; Maneval DC; Nagabhushan TL; Sugarman BJ
Cancer Gene Ther; 2001 Oct; 8(10):788-95. PubMed ID: 11687902
[TBL] [Abstract][Full Text] [Related]
12. Human renal carcinoma line transfected with interleukin-2 and/or interferon alpha gene(s): implications for live cancer vaccines.
Belldegrun A; Tso CL; Sakata T; Duckett T; Brunda MJ; Barsky SH; Chai J; Kaboo R; Lavey RS; McBride WH
J Natl Cancer Inst; 1993 Feb; 85(3):207-16. PubMed ID: 8423625
[TBL] [Abstract][Full Text] [Related]
13. Intratumoral delivery of adenovirus-mediated interleukin-12 gene in mice with metastatic cancer in the liver.
Sung MW; Chen SH; Thung SN; Zhang DY; Huang TG; Mandeli JP; Woo SL
Hum Gene Ther; 2002 Apr; 13(6):731-43. PubMed ID: 11936972
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of recombinant adenoviral vectors expressing murine IFN-alpha in mice injected with metastatic IFN-resistant tumor cells.
Santodonato L; Ferrantini M; Palombo F; Aurisicchio L; Delmastro P; La Monica N; Di Marco S; Ciliberto G; Du MX; Taylor MW; Belardelli F
Cancer Gene Ther; 2001 Jan; 8(1):63-72. PubMed ID: 11219495
[TBL] [Abstract][Full Text] [Related]
15. Interferon-alpha and antisense K-ras RNA combination gene therapy against pancreatic cancer.
Hatanaka K; Suzuki K; Miura Y; Yoshida K; Ohnami S; Kitade Y; Yoshida T; Aoki K
J Gene Med; 2004 Oct; 6(10):1139-48. PubMed ID: 15452878
[TBL] [Abstract][Full Text] [Related]
16. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-gamma-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy.
Narvaiza I; Mazzolini G; Barajas M; Duarte M; Zaratiegui M; Qian C; Melero I; Prieto J
J Immunol; 2000 Mar; 164(6):3112-22. PubMed ID: 10706701
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral IFN-α gene delivery reduces tumor-infiltrating regulatory T cells through the downregulation of tumor CCL17 expression.
Hirata A; Hashimoto H; Shibasaki C; Narumi K; Aoki K
Cancer Gene Ther; 2019 Sep; 26(9-10):334-343. PubMed ID: 30420718
[TBL] [Abstract][Full Text] [Related]
18. In vivo gene transfer of CD40 ligand into colon cancer cells induces local production of cytokines and chemokines, tumor eradication and protective antitumor immunity.
Sun Y; Peng D; Lecanda J; Schmitz V; Barajas M; Qian C; Prieto J
Gene Ther; 2000 Sep; 7(17):1467-76. PubMed ID: 11001366
[TBL] [Abstract][Full Text] [Related]
19. A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.
Yu X; Guo C; Yi H; Qian J; Fisher PB; Subjeck JR; Wang XY
Cancer Res; 2013 Apr; 73(7):2093-103. PubMed ID: 23333935
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models.
Kobayashi N; Kuramoto T; Chen S; Watanabe Y; Takakura Y
Mol Ther; 2002 Dec; 6(6):737-44. PubMed ID: 12498770
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
